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Abstract
The Tasmanian Devil Facial Tumour Disease (DFTD) provides a unique oppor-
tunity to elucidate the long-term effects of natural and anthropogenic selection
on cancer evolution. Since first observed in 1996, this transmissible cancer has
caused local population declines by >90%. So far, four chromosomal DFTD vari-
ants (strains) have been described and karyotypic analyses of 253 tumours
showed higher levels of tetraploidy in the oldest strain. We propose that increased
ploidy in the oldest strain may have evolved in response to effects of genomic
decay observed in asexually reproducing organisms. In this study, we focus on
the evolutionary response of DFTD to a disease suppression trial. Tumours
collected from devils subjected to the removal programme showed accelerated
temporal evolution of tetraploidy compared with tumours from other popula-
tions where no increase in tetraploid tumours were observed. As ploidy signifi-
cantly reduces tumour growth rate, we suggest that the disease suppression trial
resulted in selection favouring slower growing tumours mediated by an increased
level of tetraploidy. Our study reveals that DFTD has the capacity to rapidly
respond to novel selective regimes and that disease eradication may result in
novel tumour adaptations, which may further imperil the long-term survival of
the world’s largest carnivorous marsupial.
Introduction
More than 35 years ago, Nowell (1976) suggested that can-
cer progression should be regarded as an evolutionary
process. We now know that cancer is subjected to selective
regimes similar to those experienced by asexually reproduc-
ing organisms (Merlo et al. 2006). Cancer cells, like other
asexual organisms, do not undergo meiotic recombination.
How tumour cells survive the loss of heterozygosity and
the emergence of recessive mutations remains unresolved
(Sole and Deisboeck 2004). Proposed mechanisms to coun-
teract genomic decay include chromosomal rearrangements
that alter normal cell cycles and apoptotic responses, chro-
mosome breaks and tolerance of deleterious mutations
(Merlo et al. 2010).
The presence of aberrant karyotypes in malignant cells
was first observed over a century ago (von Hansemann
1890) and led to the recognition of the role of missegregat-
ing chromosomes in tumour development (Boveri 2008;
Chow and Poon 2010). Indeed, most malignant tumours
have been found to harbour structurally and numerically
rearranged chromosomes and multiple centrosomes, the
conjoint causes and consequences of abnormal mitosis
(Sen 2000; Storchova and Pellman 2004; King 2008; Storch-
ova and Kuffer 2008; Ganem et al. 2009; Little 2010;
Mosieniak and Sikora 2010). Apart from segmental chro-
mosome defects and single chromosome losses cancer cells
exhibit altered ploidy, with chromosome numbers ranging
from hypodiploid (i.e. having a chromosome number
lower than the diploid number) to hypertetraploid
© 2013 The Authors. Evolutionary Applications published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative
Commons Attribution License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited.
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(i.e. having a chromosome number greater than but not an
exact multiple of the normal diploid number; for reviews
see: Storchova and Pellman 2004; Storchova and Kuffer
2008; Davoli and de Lange 2011). Aneuploidy and poly-
ploidy have, however, been shown to provide cancer cells
with adaptive potentials (Yuen and Desai 2008). For exam-
ple, polyploidization may provide adaptive advantage to
cancer cells by masking deleterious mutations (chromo-
some losses, gene deletions and inactivating mutations)
and ameliorating the effects of deleterious recessive alleles
(Otto and Whitton 2000; Otto 2007; Davoli and de Lange
2011). Moreover, tetraploidy allows tumour cells to sustain
a higher mutation rate and may stimulate additional gen-
ome structure modifications facilitating adaptive changes.
The immediate effect of polyploidization is a general rise in
cell volume, and slower development due to increased gen-
ome size (Cavalier-Smith 1978; Gregory 2001; Otto 2007).
However, changes in ploidy also upset the geometric
machinery used to segregate chromosomes resulting in
unstable genomes, rapid genomic repatterning and
increased genetic diversity (Wendel 2000; Otto 2007). The
increased genetic polymorphism associated with tetra-
ploidy may promote the survival of certain polyploid cells,
stabilize their genomic configuration and therefore fuel the
evolution of polyploid cell populations. Thereby, poly-
ploidy not only appears to promote tumorigenesis, but also
steers cancer cell progression through a fitness landscape
during cancer evolution.
Although the evolution of neoplasm in human cancers
occur on a timescale of years, anthropogenic selection,
administered as medical treatments, has been shown to
accelerate the development of novel and aggressive as well
as drug resistant cancer strains (Merlo et al. 2010). A sig-
nificant problem when investigating how such therapies
may affect human cancer evolutionary trajectories is often
the short lifespan of both tumours and patients. The Tas-
manian Devil Facial Tumour Disease (DFTD) provides a
unique opportunity to elucidate the long-term effects of
natural and anthropogenic selection on cancer evolution.
This contagious cancer was observed first in 1996 and is
transmitted between Tasmanian devils (Sarcophilus harrisii)
by biting during social interactions (Pearse and Swift 2006;
McCallum et al. 2007; McCallum 2008; Murchison 2008).
The disease generally results in death of infected animals
within 6 months and has led to local extinctions of more
than 90%, questioning the long-term survival of this iconic
animal (Jones et al. 2007; McCallum 2008). Cytogenetic
analyses have revealed that DFTD is caused by a rogue cell
line (Pearse and Swift 2006), which originated from Schw-
ann cells of the peripheral nerve sheath (Loh et al. 2006;
Murchison et al. 2010). devil facial tumour (DFT) cells
possess a highly rearranged genome, characterized by
tumour-specific complex translocations and chromosomal
rearrangements (Pearse and Swift 2006; Deakin et al. 2012;
Pearse et al. 2012). The clonal nature of DFTs has been
supported by both large-scale genomic (Miller et al. 2011;
Murchison et al. 2012), immunohistological (Loh et al.
2006) and genetic analyses (Siddle et al. 2007, 2010; Belov
2011). Although four chromosomal variants (strains) have
been observed, exhibiting minor cytogenetic differences,
the genome of DFT cells appears to remarkably be stable
(Deakin et al. 2012; Pearse et al. 2012).
In an attempt to reduce the prevalence of DFTD, infected
devils, approximately 33%, were removed from one site,
the Forestier Peninsula, in Tasmania between 2006 and
2010 (Lachish et al. 2010; Beeton and McCallum 2011).
The disease eradication trial provides a unique opportunity
to elucidate the long-term effects of anthropogenic selec-
tion on DFTD evolution. In this study, we use karyotypic
analysis to investigate overall temporal changes of tumour
ploidy. Furthermore, we investigate the possible effects of
the removal programme on cancer evolutionary trajectories
on the Forestier Peninsula compared with other areas of
Tasmania not subjected to anthropogenic selection.
Methods
Samples
Tumour tissue samples used in the study were collected
between 2006 and 2011 at 11 sites within the DFTD-
affected areas of Tasmania (Fig. 1 which also provides data
on number of samples collected at each of the 11 sites). A
total of 253 diseased devils were analysed. Due to the trap-
ping regimes employed, we were unable to obtain compa-
rable number of samples from the 11 sites, making robust
among-site comparisons unattainable. However, as the
devil population on the Forestier Peninsula (Fig. 1) has
been subjected to a disease suppression trial, that is, the
Figure 1 Map of Tasmania showing the location of the 11 sites sam-
pled and number of samples collected at each location.
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removal of infected devils, we decided to investigate how
such artificial selection may have affected tumour evolu-
tion. Of the 149 tumours collected at Forestier Peninsula,
148 were classified as strain 3 and one as strain 2. In con-
trast to most of the other sites, no samples were collected at
Forestier Peninsula in 2011.
Cell culture
Detailed description of DFTD cell culture and cytogenetic
analysis has been previously described by Pearse et al.
(2012). Briefly tissue biopsies and fine needle aspirates were
transferred to sterile Petri dish and washed three times with
Dulbecco’s phosphate-buffered saline (Invitrogen, Carls-
bad, CA, USA), with 0.1 mL penicillin/streptomycin solu-
tion (Sigma-Aldrich, St Louis, MO, USA) and 1 mg/mL
amphotericin B (Sigma-Aldrich). Solid tissues were then
disaggregated in 3 mL of prewarmed AmnioMax C-100
medium (Invitrogen/Life Technologies, Carlsbad, CA,
USA) and homogenized in 3-mL syringe with an 18G nee-
dle until a milky single cell suspension was formed. Cancer
cells were aliquoted into 20-mL culture flasks containing
8 mL of AmnioMax C-100 media (Invitrogen/Life Tech-
nologies), 0.1 mL of penicillin-streptomycin solution
(Sigma-Aldrich), and 1 mg/mL of amphotericin B (Sigma-
Aldrich). Cultures were incubated at 35°C. Tumour cells
were harvested after 24–48 h in culture.
Cytogenetic analysis
Three hours prior to harvesting 0.1 mL of demecolcine at
10 mg/mL (Sigma-Aldrich) was added to each culture. The
cells were centrifuged for 10 min at 100 g. After the super-
natant was discarded and the cell pellet was slowly resus-
pended in 7 mL of hypotonic 0.075 M KCl and placed in a
water bath at 37°C for 10 min; 2 mL of chilled Carnoy’s
fixative (3:1 ratio of methanol and acetic acid) was added,
and the tubes were centrifuged for 10 min at 100 g. The
pellet was gently resuspended in fixative and stored at
2°C overnight. The following day, the cells were washed
49 in fresh fixative and resuspended. Chromosome spreads
were achieved by adding a droplet of the suspension onto a
frozen microscope slide. Slides were subsequently air-dried
and incubated at 57°C for 3 days. G-banding was con-
ducted by treating slides with a 0.15% solution of trypsin
(Sigma-Aldrich) for 30 s, then staining with Leishman’s
stain for 2.5 min followed by mounting with Leica mount-
ing medium (Leica Microsystems, North Ryde, NSW, Aus-
tralia) for analysis. G-banding analysis was performed
using a Leica DM 2000 microscope (Leica Microsystems)
and photographed with a Leica DFC 420 C camera (Leica
Microsystems). Karyotypes were made, originally by hand
and later (from 2008) using Video testeKaryo 3.1 software
(VideoTest, Saint Petersburg, Russia). At least 20 metapha-
ses were analysed for each individual, and approximately,
200 cells were examined.
Statistical analyses
Data were examined for normality before analysis, and
when normality could not be achieved, nonparametric sta-
tistics were employed. Logistic regression was used when
investigating temporal variation in tetraploidy among the
253 devil tumours where presence, that is, when all of 200
cells in the metaphases were recorded as being tetraploid,
was entered as ‘1’ and total absence of tetraploids was
entered as ‘0’. JMP, version 5.1 (SAS Institute Inc., Cary,
NC, USA), were used in all statistical analyses.
Results
The large number of karyotypes used in this study made it
possible to conduct robust tests to elucidate a possible vari-
ation in tetraploid tumours among the four strains. Our
results revealed a significant variation of tetraploid tumours
when employing the total number of samples collected at
the 11 sites as well as when omitting the samples collected
at the Forestier peninsula (v2 = 11.7, P = 0.008, df = 3 and
v2 = 9.6, P = 0.02, df = 3, respectively, Fig. 2). Both analy-
ses showed that the proportion of tetraploid tumours were
highest in the strain 1, the oldest of the four strains (Fig. 2).
We also observed a significant temporal increase in tetra-
ploid tumours collected at the 11 sites from 2006 to 2011
(logistic regression with tetraploidy as dependent and year
as independent variable: v2 = 16.4, P < 0.0001, df = 1;
Fig. 3A). However, when conducting the same analysis, but
excluding the tumours collected from the Forestier Penin-
sula, and hence restricting the analysis to the 10 remaining
Figure 2 Proportion of tetraploid tumours recorded in the four DFTD
strains. The numbers above the bars depict samples sizes. The two bars
at strain 3 depict the proportion of tetraploid tumours when including
(n = 154) and excluding (n = 7) the samples collected at Forestier Pen-
insula.
262 © 2013 The Authors. Evolutionary Applications published by John Wiley & Sons Ltd 7 (2014) 260–265
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sites, no temporal increase in tetraploid tumours was
observed (v2 = 0.15, P = 0.70, df = 1; Fig. 3B). A third
logistic regression analysis, restricting the data to samples
collected at Forestier Peninsula, revealed a significant tem-
poral increase in tetraploid tumours among the Forestier
devils (v2 = 35.0, P < 0.0001, df = 1; Fig. 3C), clearly
demonstrating that the overall temporal increase in tetra-
ploid tumours was caused by the increase in tetraploids at
the Forestier Peninsula.
Discussion
Devil Facial Tumour Disease is a horizontally transferred
asexually reproducing clonal cell line, which during the last
16 years have been exposed to the negative effects associ-
ated with Muller’s ratchet, resulting in mutational melt-
down and ultimately extinction. However, this obligate
parasite has been able to survive and counteract the effect
of deleterious mutations, genomic instability as well as
being able to infect >100 000 devils (McCallum 2008).
DFTD hence provides a unique opportunity to study can-
cer evolution in vivo.
Polyploidization is more common in asexual compared
to sexual organisms (Otto and Whitton 2000) and provides
an adaptive advantage to asexual organisms, such as cancer
cells, by masking deleterious mutations and ameliorating
the genomic decay process (Haldane 1933; Orr and Otto
1994; Orr 1995; Otto and Whitton 2000; Otto 2007; Davoli
and de Lange 2011). The higher number of tetraploids
recorded in the oldest DFT strain (strain 1) hence provides
a possible additional mechanism by which this asexually
reproducing obligate parasite has been able to avoid muta-
tional decay. Increased ploidy has also been associated with
slower tumour development and DFT cell growth rate
(Pearse et al. 2012). During the disease suppression trial, at
the appearance of first lesions, infected devils were removed
from Forestier Peninsula (Lachish et al. 2010; Beeton and
McCallum 2011). Such a selective regime could have
favoured slower growing DFT cells ultimately resulting
in the increased level tetraploid tumours observed at this
location.
In a recent study, Murchison et al. (2012) suggested that
the unique mitochondrial DFTD lineage present on the
Forestier Peninsula had most likely emerged due to a selec-
tive sweep. Our results provide further evidence that the
observed genetic and chromosomal changes at this site
were most likely caused by selective sweep initiated by
increased selection administrated via anthropogenic inter-
action (ongoing removal of DFTD infected devils). Unfor-
tunately, the selective culling of infected devils neither
slowed disease progression nor reduced population-level
impacts of DFTD and was therefore abandoned in 2010
(Lachish et al. 2010).
(A)
(B)
(C)
Figure 3 Logistic regression analyses of temporal variation in tetraploid
tumours. Figure (A) Depicts the variation from 2006 to 2011 using our
complete data set, that is, the analysis is based on all the 11 popula-
tions. Figure (B) Depicts the temporal variation in tetraploid tumours
excluding the samples collected at Forestier Peninsula. Figure (C)
Depicts the temporal variation in tetraploid tumours collected at the
Forestier Peninsula.
© 2013 The Authors. Evolutionary Applications published by John Wiley & Sons Ltd 7 (2014) 260–265 263
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Transition from whole-genome duplication via aneu-
ploidy to malignancy is a common feature of several
human cancers (for review see Davoli and de Lange 2011).
In spite of reducing cell proliferation rates, tetraploidiza-
tion has also been linked to the metastatic, aggressive as
well as drug resistant stages of certain human malignancies
(Castedo et al. 2006; Davoli and de Lange 2011). As sug-
gested by Davoli and de Lange (2011), such significant
changes in tumour phenotypes is most likely caused by an
enhanced ability of tetraploid tumours to sustain a higher
incidence of mutations, thereby increasing the probability
of adaptive changes and increasing the probability that
evolving tumours will accumulate mutations needed to
progress to a malignant state. If the increased level of tetra-
ploid tumours at Forestier Peninsula results in the evolu-
tion of a more malignant strain of DFTD, this may further
imperil the long-term survival of the world’s largest carniv-
orous marsupial. Although future studies are needed to
elucidate the connection between malignancies and tetra-
ploidy in DFTD, our study clearly demonstrates that DFTD
tumours are able to rapidly respond to increased selection
and adapt to a novel selective regime. Due to the observed
low genomic (Miller et al. 2011; Murchison et al. 2012)
and chromosomal polymorphism (Deakin et al. 2012; Pe-
arse et al. 2012), DFT cells have been described as a stable,
clonally evolving cell line. However, our recent studies
show that this unique cancer is a dynamically evolving obli-
gate parasite, which uses gene expression alterations (Ujvari
et al. 2012, 2013), telomere homeostasis (Ujvari et al.
2012) and epigenetic variations (Ujvari et al. 2013). The
results from the present study suggest that ploidization
may offer yet another pathway to which DFTD is able to
adapt to the ever-changing evolutionary landscape sculp-
tured by the devils’ immune system. Finally, our study is
the first to show that anthropogenic selection may enhance
cancer evolution in the wild, and it therefore cautions
about what measures we employ to try to halt the spread of
this devastating disease.
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